📍 Garden City, NY
Mon – Fri: 8:00 AM – 6:00 PM
📞 (917) 551-6652
✉️ info@davincihealthcenter.com
Request Consultation
FDA-Approved Esketamine

Spravato® Treatment for Resistant Depression

The first FDA-approved nasal spray for treatment-resistant depression. Rapid relief. In-clinic administration. Insurance may cover your treatment in Garden City, NY.

  • ✓ FDA-approved for treatment-resistant depression
  • ✓ Also approved for MDD with suicidal ideation
  • ✓ Rapid symptom improvement — many feel better within days
  • ✓ Self-administered nasal spray under medical supervision
  • ✓ REMS-certified clinic — insurance verification included

Check Your Eligibility for Spravato®

Complete this screening form. Our team will verify your insurance and contact you within 24 hours.

Medical Safety Screening: Please answer honestly so our team can determine your eligibility.
REMS Program Notice: Treatment must be administered in a certified healthcare setting with 2-hour post-dose monitoring.

🔒 HIPAA-compliant. By submitting, you consent to enrollment screening and to being contacted by Da Vinci Health Center.

✓

Screening Submitted!

Our team will verify your insurance and contact you within 24 hours.


Call Us: (917) 551-6652
2 hrs

Session incl. monitoring

2×/wk

Initial frequency

Days

Time to feel relief*

FDA

Approved treatment

About The Treatment

How Spravato® Works

Spravato® (esketamine) is the first FDA-approved nasal spray for treatment-resistant depression. It targets the NMDA receptor to rapidly improve depressive symptoms through enhanced neuroplasticity — a completely different mechanism than traditional antidepressants.

Many patients across Nassau County and Long Island experience meaningful improvement within days of starting treatment at our Garden City clinic.

Treatment Comparison

Spravato® vs. IV Ketamine

FeatureSpravato® (Esketamine)IV Ketamine
FDA StatusFDA-approvedOff-label use
AdministrationNasal sprayIntravenous infusion
InsuranceCovered by most plansTypically out-of-pocket
Monitoring2-hour observation required45–60 min infusion + monitoring
Schedule2×/week → tapering6 sessions over 2–3 weeks
REMS RequiredYes — certified clinics onlyNo REMS requirement
FAQ

Frequently Asked Questions

Yes. Spravato® is covered by most major insurance plans including Aetna, BlueCross BlueShield, Cigna, UnitedHealthcare, Medicare, and Medicaid when criteria are met. Our team handles all prior authorization paperwork.
Many patients notice meaningful improvement within the first few treatment sessions — often within days. Some notice effects even the same day as their first dose.
No. The REMS program requires that you do not drive or operate heavy machinery on the day of treatment due to potential sedation and dissociation. You must arrange transportation home and avoid driving until the next day after a full night's sleep.
REMS (Risk Evaluation and Mitigation Strategy) is an FDA safety program required for Spravato®. It means treatment can only be administered in certified healthcare settings, and patients must be monitored for at least 2 hours after each dose. Da Vinci Health Center is a fully certified REMS site.

When Traditional Antidepressants Aren't Enough

Spravato® offers a new path forward. Screening is free. Serving Garden City, Nassau County, and all of Long Island.

Check Your Eligibility →